Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

275.23
Delayed Data
As of Mar 27
 +0.41 / +0.15%
Today’s Change
205.42
Today|||52-Week Range
307.33
+5.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Quarter 4
2016
Operating ActivitiesNet Income / Starting Line969.2M1.0B1.0B647.9M
 
 
 
 
 
Depreciation149.7M175.4M180.2M177.4M
 
 
 
 
 
Total Other Cash Flow25.1M78.8M47.3M94.8M
 
 
 
 
 
Funds From Operations1.2B1.3B1.2B801.9M
 
 
 
 
 
Funds From/For Other Operating Expenses189.5M267.7M244.5M-774.7M
 
 
 
 
 
Net Cash Flow - Operating Activities963.4M995.8M986.6M1.6B
 
 
 
 
 
 
InvestingIncrease In Investments-1.9B-1.9B-1.8B-2.3B
 
 
 
 
 
Decrease In Investments1.2B1.6B2.4B2.2B
 
 
 
 
 
Capital Expenditures-126.9M-136.8M-170.3M-182.1M
 
 
 
 
 
Other Investing - Uses-343.0M-322.9M-246.9M-310.0M
 
 
 
 
 
Net Cash Flow Investing-1.2B-736.1M36.2M-581.7M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings------0.00--
Long Term Debt Reduction------0.00--
Net Proceeds Stock Sale14.5M9.4M11.3M8.5M
 
 
 
 
 
Common Preferred Redeemed0.000.00-348.9M-651.1M
 
 
 
Common Dividends----------
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing32.9M-22.8M39.7M-37.2M
 
 
 
 
 
Other Uses - Financing0.000.00------
Net Cash Flow - Financing47.4M-13.4M-300.6M-721.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash15.1M-15.0M600.0K-32.0M
 
 
 
 
 
 
Net Change In Cash-192.4M246.3M722.2M273.7M